Veterinary Medicines

Bovilis IBR marker live lyofilizát a riedidlo na suspenziu pre hovädzí dobytok

Authorised
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live
Download as PDF

Product identification

Medicine name:
Bovilis IBR marker live lyofilizát a riedidlo na suspenziu pre hovädzí dobytok
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Nasal use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live
    5.70
    log10 tissue culture infective dose 50
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
  • Nasal use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/060/03-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 27/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."